BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis
While the negative prognostic role of BRAF V600E mutation in metastatic colorectal cancer (mCRC) is well-established, the impact of BRAF codons 594 and 596 mutations, occurring in <1% of CRCs, is completely unknown. Recent studies at three Italian Institutions suggest that patients with BRAF codons 594 or 596 mutated tumors had markedly longer overall survival […]